Senisca

Senisca is a biotech start-up. They propose to create a new generation of oligonucleotide-based interventions to rewind the clock in old cells and target diseases and cosmetic signs of aging. They provide molecular and cellular biology and have patent-protected an innovation for the reversal of cellular senescence.

Senisca headquartered in Europe, operates in the Biotechnology, Health Care sector. The company focuses on Biotechnology and has secured $493.3M in funding across 48 round(s). With a team of 11-50 employees, Senisca is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Senisca, raised $4.7M. Discover more about their projects, partnerships, and impact on our platform.